SCHEMBL7455279

SCHEMBL7455279

CCCCN(c1cccc(C[C@@H](C)CN(Cc2ccccc2)C(=O)O)c1O)S(=O)(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEAD1 P28347 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
ESR1 P03372 4/20 0.42
NR1I2 O75469 1/20 0.39
LIMK1 P53667 1/20 0.39
LIMK2 P53671 1/20 0.39
ALOX5 P09917 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
MAPT P10636 1/20 0.38
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7255108 0.83 KEAP1 (0.46) KEAP1NFE2L2MAPTLMNA
SCHEMBL2579843 0.83 RORC (0.43) TEAD1KEAP1NFE2L2MEN1KMT2A
SCHEMBL2577766 0.83 MCL1 (0.44) TEAD1KEAP1NFE2L2MAPTMEN1
SCHEMBL7255192 0.83 ACHE (0.43) TEAD1ESR1MAPTMEN1KMT2A
SCHEMBL7257038 0.81 KEAP1 (0.48) KEAP1NFE2L2MAPTMEN1LMNA
SCHEMBL7252238 0.80 MAPT (0.52) L3MBTL1KEAP1NFE2L2MAPTMEN1
SCHEMBL4854967 0.76 ESR1 (0.44) L3MBTL1ESR1MAPTMEN1KMT2A
SCHEMBL5996194 0.74 CYP2C8 (0.40) ESR1KEAP1NFE2L2LMNAPSEN1
SCHEMBL5981554 0.73 MCL1 (0.39) TEAD1MAPTMEN1LMNAKMT2A
SCHEMBL7458622 0.72 RORC (0.45) LMNAPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020052399-A1 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors VAZQUEZ MICHAEL L (US) 2002-05-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020052399-A1 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors DNPEP, ASPH, PREP TEAD1 1447/4885L3MBTL1 1008/4885ESR1 1312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.